Hints and tips:
...“Investors should be focused on what this means for Warren Buffett going forward,” said Cathy Seifert, an analyst with CFRA Research. “This is a big loss....
...“Investors should be focused on what this means for Warren Buffett going forward,” Cathy Seifert, an analyst with CFRA, told DD’s Eric Platt and the FT’s Harriet Agnew, underscoring the personal effect this...
...“We as a country and as a society are at an inflection point and that’s being mirrored in the investment community,” said Cathy Seifert, an analyst who covers the company at CFRA Research....
...Seifert described Buffett’s response as a “little disconcerting”, adding: “this is not how the head of a significant company [should act]. This should be taken very seriously.”...
...in recent years to find companies worth adding to Berkshire’s portfolio and its record over the past decade has been a “mixed bag” filled with “integration issues [and] overpaying” for deals, said Cathy Seifert...
...likely applaud share buybacks in the quarter . . . but are also likely to remain focused on Berkshire’s $100bn-plus in cash and the potential acquisitions that could be made with those assets,” said Cathy Seifert...
...Additional reporting by Patrick Temple-West eric.platt@ft.com...
...“This is a good example of where lean can be too lean,” said Cathy Seifert, an analyst who covers Berkshire at CFRA Research....
...“They paid up for that deal and I would not characterise the integration of Precision Castparts as a stunning success,” said Cathy Seifert, an analyst who covers the company at CFRA Research....
...“Those two things, I believe, have really tarnished Berkshire’s reputation for dealmaking,” Ms Seifert said of the two investments. The Occidental deal “was an unmitigated disaster”....
...“They paid up for that deal and I would not characterise the integration of Precision Castparts as a stunning success,” Cathy Seifert, an analyst who covers the company at CFRA Research, told DD’s Eric Platt...
...Dr Eric Siemers, a Lilly scientist who worked on Sola, is not so sure....
...Weekend videos Letters in response to this article: Do not discount the totalitarian terror of ‘We’ / From Luc Haenen, Boechout, Belgium Two depictions of dystopia that are ‘doubleplusgood’ / From Daniel Seifert...
...Cathy Seifert, insurance analyst at CFRA Research, said she expected insurance and reinsurance stocks to remain volatile....
...“The results provide encouraging evidence that solanezumab could indeed be acting on the disease processes that drive Alzheimer’s,” said Eric Karran, research director at Alzheimer’s Research UK, the charity...
...“FGIC has told us they will be formally requesting approval to split into two,” said a spokesman for Eric Dinallo, New York’s insurance superintendent, who regulates many of the big bond insurers and is...
International Edition